ArticleArchives of public health = Archives belges de sante publique2021
Recommendations to plan a national burden of disease study.
Article in Archives of public health = Archives belges de sante publique, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Pre-pandemic sub-national disparities in the disease burden of ischemic heart disease and stroke in France.BMC cardiovascular disorders · 2026Article
- Sub-national disparities in disease burden of diabetes mellitus and chronic kidney disease in France: a pre-pandemic analysis.Archives of public health = Archives belges de sante publique · 2025Article
- Article
- Global, regional, and national burden of musculoskeletal disorders, 1990-2021: an analysis of the global burden of disease study 2021 and forecast to 2035.Frontiers in public health · 2025Article
- Measuring the Burden of Disease in Korea Using Disability-Adjusted Life Years (2008-2020).Journal of Korean medical science · 2024Article
- Trends in Healthy Life Expectancy (HALE) and Disparities by Income and Region in Korea (2008-2020): Analysis of a Nationwide Claims Database.Journal of Korean medical science · 2024Article
- Knowledge management tools and mechanisms for evidence-informed decision-making in the WHO European Region: a scoping review.Health research policy and systems · 2023Article
- Estimating the burden of disease attributable to high ambient temperature across climate zones: methodological framework with a case study.International journal of epidemiology · 2023Article
- Direct impact of COVID-19 by estimating disability-adjusted life years at national level in France in 2020.PloS one · 2023Article
- Burden of Disease (BoD) Assessment to Estimate Risk Factors Impact in a Real Nanomanufacturing Scenario.Nanomaterials (Basel, Switzerland) · 2022Article
- Disability adjusted life years associated with COVID-19 in Denmark in the first year of the pandemic.BMC public health · 2022Article
- A scoping review of burden of disease studies estimating disability-adjusted life years due to Taenia solium.PLoS neglected tropical diseases · 2022Article
- The InfAct proposal for a sustainable European health information infrastructure on population health: the Distributed Infrastructure on Population Health (DIPoH).Archives of public health = Archives belges de sante publique · 2022Article
- Burden of Disease of COVID-19: Strengthening the Collaboration for National Studies.Frontiers in public health · 2022Review
- Measuring the Burden of Disease in Korea, 2008-2018.Journal of preventive medicine and public health = Yebang Uihakhoe chi · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundThe InfAct (Information for Action) project is a European Commission Joint Action on Health Information which has promoted the potential role of burden of disease (BoD) approaches to improve the current European Union-Health Information System (EU-HIS). It has done so by raising awareness of the concept, the methods used to calculate estimates and their potential implications and uses in policymaking. The BoD approach is a systematic and scientific effort to quantify and compare the magnitude of health loss due to different diseases, injuries, and risk factors with estimates produced by demographic characteristics and geographies for specific points in time. Not all countries have the resources to undertake such work, and may therefore start with a more restricted objective, e.g., a limited number of diseases, or the use of simple measures of population health such as disease prevalence or life expectancy. The main objective to develop these recommendations was to facilitate those countries planning to start a national burden of disease study.
resultsThese recommendations could be considered as minimum requirements for those countries planning to start a BoD study and includes following elements: (1) Define the objectives of a burden of disease study within the context of your country, (2) Identify, communicate and secure the benefits of performing national burden of disease studies, (3) Secure access to the minimum required data sources, (4) Ensure the minimum required capacity and capability is available to carry out burden of disease study, (5) Establish a clear governance structure for the burden of disease study and stakeholder engagement/involvement, (6) Choose the appropriate methodological approaches and (7) Knowledge translation. These were guided by the results from our survey performed to identify the needs of European countries for BoD studies, a narrative overview from four European countries (Belgium, Germany, The Netherlands and Scotland) and the summary of a comparative study of country health profiles with national health statistics.
conclusionsThese recommendations as minimum requirements would facilitate efforts by those European countries who intend to perform national BoD studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.